Close
Show

Press Releases

Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

Hagens Berman: Pennsylvania Woman with Fungal Meningitis Sues Drug Manufacturer


A Red Lion, Pennsylvania woman stricken with fungal meningitis filed a lawsuit last Friday...

Significant Blood Pressure Reduction from St. Jude Medical’s EnligHTN Renal Denervation Technology is Safe,...


St. Jude Medical, Inc., a global medical device company, today announced that the company’s...

Curie-Cancer and Harmonic Pharma sign a partnership agreement for exploring the anti-cancer activity of...


Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities and Harmonic Pharma,...

Merck Resolves Previously Disclosed Missouri Consumer Class Action Lawsuit Related to Vioxx


Merck, known as MSD outside the United States and Canada, today confirmed terms of...

Genzyme Announces Publication of LEMTRADATM (alemtuzumab) Pivotal Studies in The Lancet


Genzyme, aSanofi company , announced today the publication of results from the LEMTRADA™ (alemtuzumab)...

Ariana(R) Pharma and CTCLS sign Japanese distribution agreement for data analysis technology


Ariana Pharma, the premium provider of advanced, non-statistical clinical data and biomarker analytics technology across...

Adocia announces the strong growth of its turnover


Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines with already...

TxCell announces publication of CATS1 study results for antigen-specific Treg therapy in Crohn¹s disease...


TxCell SA, a biotechnology company developing cell-based immunotherapies for the treatment of severe chronic...

Cytheris announces US Orphan Drug Designation for CYT107 for the treatment of Progressive Multifocal...


Cytheris SA, a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today that...

Domain Therapeutics enters into collaboration agreement with Ono in the field of GPCR-based drug...


Domain Therapeutics S.A. announced today that Domain Therapeutics and Ono Pharmaceutical Co., Ltd. (Osaka,...